NM_001143832.2:c.-84+2158G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001143832.2(LEUTX):c.-84+2158G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.261 in 151,980 control chromosomes in the GnomAD database, including 5,835 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.26 ( 5833 hom., cov: 31)
Exomes 𝑓: 0.30 ( 2 hom. )
Consequence
LEUTX
NM_001143832.2 intron
NM_001143832.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.188
Publications
4 publications found
Genes affected
LEUTX (HGNC:31953): (leucine twenty homeobox) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be part of chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.473 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.261 AC: 39692AN: 151798Hom.: 5833 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
39692
AN:
151798
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.297 AC: 19AN: 64Hom.: 2 Cov.: 0 AF XY: 0.364 AC XY: 16AN XY: 44 show subpopulations
GnomAD4 exome
AF:
AC:
19
AN:
64
Hom.:
Cov.:
0
AF XY:
AC XY:
16
AN XY:
44
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
2
AN:
18
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
16
AN:
42
Other (OTH)
AF:
AC:
1
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.528
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.261 AC: 39697AN: 151916Hom.: 5833 Cov.: 31 AF XY: 0.264 AC XY: 19565AN XY: 74194 show subpopulations
GnomAD4 genome
AF:
AC:
39697
AN:
151916
Hom.:
Cov.:
31
AF XY:
AC XY:
19565
AN XY:
74194
show subpopulations
African (AFR)
AF:
AC:
5024
AN:
41468
American (AMR)
AF:
AC:
4577
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
AC:
1190
AN:
3472
East Asian (EAS)
AF:
AC:
2521
AN:
5154
South Asian (SAS)
AF:
AC:
1807
AN:
4806
European-Finnish (FIN)
AF:
AC:
2853
AN:
10520
Middle Eastern (MID)
AF:
AC:
92
AN:
294
European-Non Finnish (NFE)
AF:
AC:
20612
AN:
67932
Other (OTH)
AF:
AC:
587
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1414
2828
4241
5655
7069
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
428
856
1284
1712
2140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1384
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.